This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
Retraction: Identification of Nitric Oxide as an Endogenous Inhibitor of 26S Proteasomes in Vascular Endothelial Cells
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsUbiquitin and proteasome pathways · Coenzyme Q10 studies and effects · Protease and Inhibitor Mechanisms
Following publication of this article [1], the University of Oklahoma Health Campus (OUHC) notified PLOS that an institutional investigation determined there was falsification in Figs 1B and 11B. Specifically, OUHC reported the following findings to PLOS:
During editorial follow-up, the corresponding author JX stated that the data underlying the panels of concern are no longer available.
In light of the concerns raised about the reliability of the reported results, and in accordance with the request of the University of Oklahoma Health Campus, the PLOS One Editors retract this article.
JX did not agree with the retraction and stands by the article’s findings. HL, SY, and HZ either did not respond directly or could not be reached.
The reference list from the paper itself. Each links out to its DOI / PubMed record.